Enhanced COPD Management in Suspected Lung Cancer Patients
Eligible age
18+ yrs
Accepts
All genders
Locations
0 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
Identifying and treating COPD in patients undergoing lung cancer evaluation is crucial. Early intervention could lead to better management of both diseases, improving health status, reducing healthcare costs, and potentially increasing survival rates. This study aims to assess the impact of early diagnosis and optimal treatment of COPD on clinical outcomes in patients under evaluation for lung cancer. The study will combine information through an open-label RCT at the Lung Cancer Investigation Unit at Lillebaelt Hospital Vejle. The findings could inform clinical practice by emphasizing the importance of integrated care approaches for patients with coexisting COPD and lung cancer, ultimately leading to better health outcomes.
Sponsor: Ditte Krag-Hansen
You may qualify if…
- ✓ Undergoing diagnostic evaluation for suspected lung cancer
- ✓ Spirometry showing obstructive airflow limitation (FEV₁/FVC \< 75 % or FEV₁ \< 80 %, and no reversibility) at the first outpatient visit at the lung cancer evaluation
You may not qualify if…
- ✕ Presence of significant comorbidities that may interfere with diagnostic procedures or spirometry
- ✕ Pregnant or breastfeeding women
Source: ClinicalTrials.gov · NCT07543601 · last updated 2026-04-22